Evidence map›Paper›PMID 42367209›Full record

ArticleBio-protocol2026

Amplification-Free Detection of Highly Structured RNA Molecules Using SCas12aV2.

Teng Hu, Youyang Pei, Zhaoyi Hu, Jing Feng, Qiangyuan Jiang, Li Hu, Yi Liu

Abstract read
In one paragraph

Article in Bio-protocol, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Teng HuHubei Light Industry Technology Institute, Hubei, China.
Youyang PeiHubei Light Industry Technology Institute, Hubei, China.
Zhaoyi HuHubei Light Industry Technology Institute, Hubei, China.
Jing FengHubei Light Industry Technology Institute, Hubei, China.
Qiangyuan JiangState Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Sciences, Hubei University, Hubei, China.
Li HuHubei Light Industry Technology Institute, Hubei, China.
Yi LiuState Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Sciences, Hubei University, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The CRISPR/Cas12a system has revolutionized molecular diagnostics; however, conventional Cas12a-based methods for RNA detection typically require transcription and pre-amplification steps. Our group has recently developed a diagnostic technique known as the SCas12a assay, which combines Cas12a with a split crRNA, achieving amplification-free detection of miRNA. However, this method still encounters challenges in accurately quantifying long RNA molecules with complex secondary structures. Here, we report an enhanced version termed SCas12aV2 (split-crRNA Cas12a version 2 system), which enables direct detection of RNA molecules without sequence limitation while demonstrating high specificity in single-nucleotide polymorphism (SNP) applications. We describe the general procedure for preparing the SCas12a system and its application in detecting RNA targets from clinical samples. Key features • The SCas12aV2 assay enables efficient detection of long-chain RNA molecules with complex secondary structures. • PAM-distal sites can be effectively distinguished at the SNP detection level. • The entire experimental procedure can be completed in less than one hour.

Indexed as

CRISPR/Cas12acrRNAScaffold RNASCas12a systemSpacer RNA

Identifiers

PMID42367209
PMCPMC13293984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.